Abbott SCSPENDING
Nevro SCSPENDING
Cyclosporiasis OutbreakPENDING
Apple AirTagPENDING
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
ACTIVE
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
ACTIVE
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
QUIET
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
ACTIVE
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
ACTIVE
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
ACTIVE
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
MONITOR
Video Game Addiction
MONITOR
CA Women's Prisons
ACTIVE
Zantac
QUIET
Dupixent CTCL
MONITOR
Boston Sci. SCS
MONITOR
ByHeart Formula
MONITOR
Cartiva
ACTIVE
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
ACTIVE
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
ACTIVE
UPF Litigation
MONITOR
48Tracked
30Active
4Pending
Navigation
Abbott SCSPENDING
Nevro SCSPENDING
Cyclosporiasis OutbreakPENDING
Apple AirTagPENDING
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
ACTIVE
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
ACTIVE
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
QUIET
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
ACTIVE
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
ACTIVE
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
ACTIVE
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
MONITOR
Video Game Addiction
MONITOR
CA Women's Prisons
ACTIVE
Zantac
QUIET
Dupixent CTCL
MONITOR
Boston Sci. SCS
MONITOR
ByHeart Formula
MONITOR
Cartiva
ACTIVE
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
ACTIVE
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
ACTIVE
UPF Litigation
MONITOR
48Tracked
30Active
4Pending
LexGenius Logo
LexGeniusYour Edge in Mass Litigation
PricingDaily DocketTrack litigations freeSign in
LexGenius

LexGenius

Your Edge in Mass Litigation

DisclaimerAcceptable UseTermsPrivacyCookie PolicySupport

© 2026 LexGenius. All rights reserved.

Mid-stage / Daubert pending● ACTIVE230 eventsProduct Liability

Hair Relaxer

Pharmaceutical · claims linking chemical hair relaxers to reproductive cancers and endocrine disruption

Defendant

L'Oréal USA, Inc.

MDL / Track

MDL 3060

N.D. Ill.

Judge

Judge Mary M. Rowland

Plaintiffs

~11,695 pending (11,440 per JPML's March 2, 2026 report, plus ~255 new filings tracked since)

Bellwether / Trial

No verdicts yet

Settlement Status

  • No global settlement announced
  • Special Master Ellen K. Reisman appointed April 2025 to facilitate discussions
  • industry observers expect framework only after Daubert rulings and initial verdicts
Home/Torts/Hair Relaxer
SharePost on XShare on BlueskyShare on LinkedInShare on FacebookEmail

Track litigations for free. Save this matter, capture notes, and monitor live signals.

Sign in
← Torts Case overview Litigation status Geographic exposure Key defendants Timeline Statute of limitations Live activity Leadership News PubMed openFDA Court filings

Case overview

MDL 3060, In re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation, has grown to 11,877 pending cases before Judge Mary M. Rowland in the Northern District of Illinois as of July 1, 2026. Daubert briefing on general causation expert admissibility runs through late 2026, with the first bellwether trial scheduled for late 2026 and a second approximately three months later. Judge Rowland held Science Day on January 8, 2026, and personally selected bellwether cases after rejecting party-driven selection.

Causation Theory

The October 2022 NIH Sister Study, published in the Journal of the National Cancer Institute by Chang et al., followed 33,497 women for a mean 10.9 years and found women using chemical hair straighteners more than four times annually had a hazard ratio of approximately 2.55 for uterine cancer. Plaintiffs' theory posits chronic scalp absorption and inhalation of endocrine-disrupting chemicals in relaxer formulations—including phthalates, parabens, formaldehyde and formaldehyde-releasing agents, and bisphenol A—produce cumulative body burden that disrupts hormone function and drives hormone-sensitive cancers. The International Agency for Research on Cancer classifies formaldehyde as a known human carcinogen.

Case Management Orders

Litigation status

MDL 3060 is in final pretrial posture before bellwether trials. Judge Mary M. Rowland in the Northern District of Illinois assumed direct control of bellwether selection in April 2026, naming 10 cases from a 32-case discovery pool. Case-specific Daubert and summary judgment motions are due November 16, 2026, with initial trials anticipated in 2027. A Special Master continues facilitating settlement discussions.

MDL Track

MDL 3060

N.D. Ill.

Hair relaxer marketing, sales practices, and products liability

11,440 pending

State Court Activity

Parallel state litigation active; Arizona filed suit against L'Oréal in September 2026; Philadelphia mass tort docket ongoing with discovery disputes including appeal of executive deposition order

MDL 3060 Leadership

Plaintiff Leadership

Co-Lead Counsel

Benjamin L. Crump

Ben Crump Law Firm

ben@bencrump.com(850) 224-2020

Fidelma Fitzpatrick

Motley Rice LLC

ffitzpatrick@motleyrice.com(401) 457-7728

Michael A. London

Douglas & London, P.C.

mlondon@douglasandlondon.com212-566-7500

Diandra "Fu" Debrosse Zimmermann

DiCello Levitt LLC

fu@dicellolevitt.com205-855-5700

Liaison Counsel

Edward A. Wallace

Wallace Miller

eaw@wallacemiller.com312 261-6193

Executive Committee Member

Brian Barr

Levin Papantonio Rafferty

bbarr@levinlaw.com850 435-7044

Tim Becker

Johnson Becker

tbecker@johnsonbecker.com612 436-1804

Jayne Conroy

Simmons Hanly Conroy

jconroy@simmonsfirm.com212 257-8482

Kelly M. Dermody

Lieff Cabraser Heimann & Bernstein

kdermody@lchb.com415 956-1000

Jennifer Hoekstra

Aylstock, Witkin, Kreis & Overholtz, PLLC

jhoekstra@awkolaw.com850 202-1010

LaRuby May

May Jung

laruby@mayjung.com202 938-3524

Rene F. Rocha

Morgan & Morgan

rrocha@forthepeople.com954 318-0268

Larry Taylor

The Cochran Firm

ltaylor@cochrantexas.com214 466-7620

Navan Ward

Beasley Allen

navan.ward@beasleyallen.com404 751-1162

Steering Committee Member

Anne Andrews

Andrews & Thornton

aa@andrewsthornton.com949 748-1000

Greg Cade

Environmental Law Group

gregc@elglaw.com205 328-9200

Thomas P. Cartmell

Wagstaff & Cartmell LLP

tcartmell@wcllp.com816 701-1100

Andrew Childers

Childers, Schleuter & Smith

achilders@cssfirm.com404 419-9500

Erin Copeland

Fibich Leebron Copeland & Briggs

ecopeland@fibichlaw.com713 751-0025

Maria Fleming

Napoli Shkolnik

mfleming@napolilaw.com844 230-7676

Lee Floyd

Breit Biniazan

lee@bbtrial.com804 351-9040

Kendra Y. Goldhirsch

Chaffin Luhana LLP

goldhirsch@chaffinluhana.com888 480-1123

Kristine Kraft

Schlichter Bogard & Denton

kkraft@uselaws.com314 884-7706

Buffy Martines

Laminack, Pirtle & Martines

buffym@lpm-triallaw.com713 292-2750

Melanie Muhlstock

Parker Waichman

mmuhlstock@yourlawyer.com516 466-6500

David A. Neiman

Romanucci & Blandin, LLC

dneiman@rblaw.net312 253-8810

Geographic exposure

NIH Sister Study (October 2022): 33,497 women followed 10.9 years; women using chemical hair straighteners >4 times/year had 2.55x uterine cancer risk. Black women: 60% of study participants using straighteners; 60-80% lifetime use prevalence. Postmenopausal Black women with frequent/long-term use: >50% increased uterine cancer risk. Affected population: millions of regular users; statute of limitations governed by discovery rule from October 2022 study publication.

  • Federal MDL 3060

    In re: Hair Relaxer Marketing Sales Practices and Products Liability Litigation, MDL 3060, U.S. District Court for the Northern District of Illinois before Judge Mary M. Rowland. 11,526 pending cases as of May 1, 2026. Defendants: L'Oréal USA, Revlon, SoftSheen-Carson, Strength of Nature, Namaste Laboratories. Claims: uterine, ovarian, endometrial cancer; uterine fibroids requiring hysterectomy. Bellwether selection: 32 cases (16 plaintiff-selected, 16 defendant-selected) as of May 9, 2025. Expert discovery concludes October 2026; first bellwether trials projected late 2026/early 2027.

  • Illinois

    Judge Rowland dismissed L'Oréal S.A. (French parent) June 2025 for lack of personal jurisdiction; mere patent ownership and licensor-licensee relationship insufficient. Walgreens Co. dismissed June 20, 2025; plaintiff failed to identify specific products purchased beyond single 2010 transaction. Litigation proceeds against U.S. manufacturers and distributors only.

  • Georgia

    Original state court venue for class action and individual suits consolidated into MDL 3060. No active state court proceedings remain for these claims.

  • New York

    Original state court venue for class action suits removed to MDL 3060. No active state court proceedings remain for these claims.

  • California

    Original state court venue for class action suits removed to MDL 3060. No active state court proceedings remain for these claims.

  • Ohio

    Original state court venue for class action suits removed to MDL 3060. No active state court proceedings remain for these claims.

  • Tennessee

    Original state court venue for class action suits removed to MDL 3060. Allegations included racial discrimination in marketing to Black and Brown girls and women. No active state court proceedings remain for these claims.

  • United Kingdom (Milton Keynes)

    Occupational exposure claim: hairdresser Louisa Curtis represented by Slater and Gordon, alleging long-term formaldehyde exposure from keratin smoothing treatments (2008-2026). Acute respiratory injury March 2026. No U.S. MDL established for occupational salon worker claims; U.S. exposure studies (CDC, OSHA) document airborne formaldehyde in salon settings during keratin treatments.

Key defendants

L'Oréal USA, Inc.

Role: Manufacturer

Named in Master Short-Form Complaint (Doc. 106-1, 1:23-cv-00818) for Dark & Lovely, Optimum, Mizani brands. Core Phase I defendant with SoftSheen-Carson LLC.

SoftSheen-Carson LLC

Role: Manufacturer

L'Oréal subsidiary named in Master Short-Form Complaint for hair relaxer brands. Jointly sued with parent; no separate dismissal motion found in results.

Revlon, Inc.

Role: Manufacturer

Named in Master Short-Form Complaint for Crème of Nature, Revlon Realistic brands. Filed Chapter 11 bankruptcy in 2023; litigation posture complicated by restructuring.

Strength of Nature, LLC

Role: Manufacturer

Named in Master Short-Form Complaint for Motions, Just for Me, Soft & Beautiful, TCB, TCB Naturals brands. Godrej SON Holdings affiliate; active in MDL 3060.

John Paul Mitchell Systems

Role: Manufacturer

Motion to dismiss denied 2/19/2025 (Doc. 1098). Judge Rowland rejected 12(b)(1) and 12(b)(6) challenges; ~37 plaintiffs actively pursuing claims.

Advanced Beauty Inc.

Role: Manufacturer

Motion to dismiss denied 2/19/2025 (Doc. 1097). Judge Rowland found standing and causation allegations sufficient; ~40 plaintiffs from 18 states.

DefendantRoleIntelligence Note
L'Oréal USA, Inc.ManufacturerNamed in Master Short-Form Complaint (Doc. 106-1, 1:23-cv-00818) for Dark & Lovely, Optimum, Mizani brands. Core Phase I defendant with SoftSheen-Carson LLC.
SoftSheen-Carson LLCManufacturerL'Oréal subsidiary named in Master Short-Form Complaint for hair relaxer brands. Jointly sued with parent; no separate dismissal motion found in results.
Revlon, Inc.ManufacturerNamed in Master Short-Form Complaint for Crème of Nature, Revlon Realistic brands. Filed Chapter 11 bankruptcy in 2023; litigation posture complicated by restructuring.
Strength of Nature, LLCManufacturerNamed in Master Short-Form Complaint for Motions, Just for Me, Soft & Beautiful, TCB, TCB Naturals brands. Godrej SON Holdings affiliate; active in MDL 3060.
John Paul Mitchell SystemsManufacturerMotion to dismiss denied 2/19/2025 (Doc. 1098). Judge Rowland rejected 12(b)(1) and 12(b)(6) challenges; ~37 plaintiffs actively pursuing claims.
Advanced Beauty Inc.ManufacturerMotion to dismiss denied 2/19/2025 (Doc. 1097). Judge Rowland found standing and causation allegations sufficient; ~40 plaintiffs from 18 states.

Timeline

  1. 2022-10

    NIH Sister Study Published

    Chang et al. published findings in Journal of the National Cancer Institute (PMID: 36245087) analyzing 33,497 women over ~11 years; frequent hair straightener users (4+ times/year) had approximately 2.5 times the risk of uterine cancer. First lawsuits filed within days.

  2. 2023-02

    MDL 3060 Formed

    Judicial Panel on Multidistrict Litigation centralized federal hair relaxer cases in In re: Hair Relaxer Marketing, Sales Practices and Products Liability Litigation, MDL 3060, before Judge Mary M. Rowland in the Northern District of Illinois. Master Docket No. 23 CV 0818.

  3. 2023-11

    Court Denies Motions to Dismiss Core Claims

    Judge Rowland largely denied manufacturers' motions to dismiss, allowing failure-to-warn and design defect claims to proceed.

  4. 2025-02

    Additional Defendants Kept in Litigation

    Judge Rowland denied dismissal motions for Wella and John Paul Mitchell Systems. Joint status report filed January 10, 2025 proposed bellwether selection process with 20-case nominations due April 30, 2025.

  5. 2025-04

    Special Master Appointed for Settlement

    Judge Rowland appointed Ellen K. Reisman as Special Master to facilitate settlement discussions. Both parties submitted 20 bellwether case nominations each (40 total).

  6. 2026-01

    Science Day Held

    Judge Rowland held court's first formal Science Day on January 8, 2026, with experts from both sides presenting causation evidence linking chemical straighteners to hormone-related cancers.

  7. 2026-04

    Judge Selects Bellwether Cases, Daubert Motions Filed

    Judge Rowland personally selected 10 bellwether cases from 32-case pool after scrapping party-driven selection process. Defendants filed Daubert motions challenging plaintiffs' general causation experts by April 1, 2026 deadline.

  8. 2026-05

    MDL Reaches 11,500+ Pending Cases

    MDL 3060 grew to 11,526 pending cases as of May 1, 2026. Discovery and Daubert briefing ongoing. No settlements reached.

  9. 2026-11

    Daubert and Summary Judgment Briefing Closes

    November 16, 2026 deadline for summary judgment and non-causation Daubert motions; January 6, 2027 deadline for final replies. Rulings expected to determine whether bellwether trials proceed.

  10. 2027

    First Bellwether Trials Expected

    First bellwether trial anticipated in early to mid-2027, contingent on Judge Rowland's Daubert rulings. Second trial scheduled approximately three months later.

Statute of limitations

MDL No. 3060 (In re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation) pending before Judge Mary M. Rowland in N.D. Ill. per search result [6]. FDA formaldehyde ban rule stalled by January 2025 regulatory freeze executive order per search result [6]. Revlon bankruptcy: Hair Straightener Bar Date of April 11, 2023 has passed; late claims require leave of court per In re RML, LLC, 657 B.R. 709 (Bankr. S.D.N.Y. 2023), search result [7]. Screen for bankruptcy bar date exposure on all Revlon/ColorProof claims. California and Texas removed from draft—no supporting citations in search results.

Illinois

2 years from injury

Rule: 735 ILCS 5/13-202; product liability claims accrue upon injury

Discovery: Discovery rule applies; accrual when plaintiff knows or should know of injury and its cause

MDL No. 3060 centralized in N.D. Ill. before Judge Mary M. Rowland per search result [6]. State court actions referenced in search result [6].

Florida

4 years from injury; 2 years for wrongful death

Rule: Fla. Stat. § 95.11(3)(a), (e); product liability statute runs from date of injury

Discovery: Discovery rule recognized; statute begins when injury is or should be discovered with due diligence

Confirmed in search result [4].

New York

3 years from injury

Rule: CPLR § 214(2); product liability claims subject to three-year limitations period

Discovery: Discovery rule applies; continuous use doctrine may extend accrual for latent injuries

State court actions referenced in search result [6]. Revlon bankruptcy: Hair Straightener Bar Date of April 11, 2023 passed; late claims require leave of court per In re RML, LLC, 657 B.R. 709 (Bankr. S.D.N.Y. 2023), search result [7].

Georgia

2 years from injury

Rule: O.C.G.A. § 9-3-33; strict product liability claims subject to two-year period

Discovery: Discovery rule applies; accrual upon reasonable discovery of injury and causal connection

State court litigation active per search result [6].

Pennsylvania

2 years from injury

Rule: 42 Pa. C.S. § 5524; product liability claims subject to two-year limitations

Discovery: Discovery rule applies; statute tolls until plaintiff knows or reasonably should know of injury and cause

State court actions referenced in search result [6].

StateSOLRuleDiscovery RuleNotes
Illinois2 years from injury735 ILCS 5/13-202; product liability claims accrue upon injuryDiscovery rule applies; accrual when plaintiff knows or should know of injury and its causeMDL No. 3060 centralized in N.D. Ill. before Judge Mary M. Rowland per search result [6]. State court actions referenced in search result [6].
Florida4 years from injury; 2 years for wrongful deathFla. Stat. § 95.11(3)(a), (e); product liability statute runs from date of injuryDiscovery rule recognized; statute begins when injury is or should be discovered with due diligenceConfirmed in search result [4].
New York3 years from injuryCPLR § 214(2); product liability claims subject to three-year limitations periodDiscovery rule applies; continuous use doctrine may extend accrual for latent injuriesState court actions referenced in search result [6]. Revlon bankruptcy: Hair Straightener Bar Date of April 11, 2023 passed; late claims require leave of court per In re RML, LLC, 657 B.R. 709 (Bankr. S.D.N.Y. 2023), search result [7].
Georgia2 years from injuryO.C.G.A. § 9-3-33; strict product liability claims subject to two-year periodDiscovery rule applies; accrual upon reasonable discovery of injury and causal connectionState court litigation active per search result [6].
Pennsylvania2 years from injury42 Pa. C.S. § 5524; product liability claims subject to two-year limitationsDiscovery rule applies; statute tolls until plaintiff knows or reasonably should know of injury and causeState court actions referenced in search result [6].

Live intelligence

AI litigation brief

Hair Relaxer remains mid-stage / daubert pending with 230 current signals in the accepted feed.

Overview

MDL 3060 is in final pretrial posture before bellwether trials. Judge Mary M. Rowland in the Northern District of Illinois assumed direct control of bellwether selection in April 2026, naming 10 cases from a 32-case discovery pool. Case-specific Daubert and summary judgment motions are due November 16, 2026, with initial trials anticipated in 2027. A Special Master continues facilitating settlement discussions.

Key developments

  • PACER court filing on Dec 31: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation
  • KOLD news on Sep 28: Arizona sues L’Oréal, claims hair relaxer chemicals raise women’s cancer risk - KOLD

Trajectory

Court filings and press coverage are both active in MDL 3060, pointing to sustained litigation pressure rather than a one-off headline cycle. 6 live sources are contributing current context.

Editorial intelligence

MDL 3060 should stay on the lead docket watch because it is the primary consolidation vehicle for Hair Relaxer.

Generated Sep 30, 2026, 10:00 AM UTC

230 events detected

Google News (29)

  • Arizona sues L’Oréal, claims hair relaxer chemicals raise women’s cancer risk - KOLD

    KOLDSep 28, 2026, 2:28 PM UTC
  • Hair Relaxer Cancer Lawsuit: What’s Been Proven So Far - Legal Desire

    Legal DesireSep 22, 2026, 9:22 AM UTC
  • L’Oréal faces lawsuit in the US over hair relaxer cancer risk links - Cosmetics Business

    Cosmetics BusinessSep 16, 2026, 10:37 AM UTC
  • Arizona Is Suing L’Oréal Over Cancer-Causing Ingredients in Hair Relaxers - Consumer Reports

    Consumer ReportsSep 15, 2026, 6:38 PM UTC
  • Arizona Sues L’Oréal Over Alleged Cancer Risks Linked to Hair Relaxers - Global Cosmetics News

    Global Cosmetics NewsSep 15, 2026, 5:04 AM UTC
  • A New Lawsuit Alleges L’Oréal Downplayed Cancer Risks of Chemical Hair Relaxers - Allure

    AllureSep 14, 2026, 8:36 PM UTC
  • Arizona Is Taking L'Oreal to Court - Newser

    NewserSep 14, 2026, 5:20 PM UTC
  • Arizona Sues L’Oreal for Masking Cancer Risks in Hair Relaxers - Beauty Packaging

    Beauty PackagingSep 14, 2026, 3:46 PM UTC
  • L'Oréal Accused of Selling Hair Relaxers Linked to Uterine and Ovarian Cancer Without Warning Women - Fashion Times UK

    Fashion Times UKSep 14, 2026, 7:56 AM UTC
  • Arizona accuses L'Oreal of concealing cancer risks linked to hair relaxers - Red Lake Nation News

    Red Lake Nation NewsSep 14, 2026, 3:57 AM UTC
  • Globally Popular Haircare Brand Sued Over Hair Relaxers & Cancer Risk: What Does The Science Say? - Health and Me

    Health and MeSep 13, 2026, 1:00 PM UTC
  • Arizona Sues L’Oréal, Says It Hid Cancer Risks in Hair Relaxers - lawcommentary.com

    lawcommentary.comSep 13, 2026, 7:00 AM UTC
  • Arizona sues L'Oreal over alleged cancer risks in hair relaxers - USA Today

    USA TodaySep 12, 2026, 11:38 PM UTC
  • Arizona sues L’Oreal over alleged cancer risks of hair relaxers - en.bd-pratidin.com

    en.bd-pratidin.comSep 12, 2026, 9:22 PM UTC
  • Arizona sues L’Oréal over alleged cancer risks from hair relaxers - UA.NEWS

    UA.NEWSSep 12, 2026, 8:52 AM UTC
  • US state accuses L’Oreal of concealing cancer risks linked to hair relaxers - Free Malaysia Today

    Free Malaysia TodaySep 12, 2026, 5:28 AM UTC
  • What Arizona AG Kris Mayes alleges about L’Oréal hair relaxers - AZ Family

    AZ FamilySep 12, 2026, 12:10 AM UTC
  • L’Oréal faces Arizona suit over alleged hair relaxer cancer risks (LRLCF:OTCMKTS) - Seeking Alpha

    Seeking AlphaSep 11, 2026, 8:15 PM UTC
  • Arizona accuses L’Oréal of concealing cancer risks linked to hair relaxers - The Guardian

    The GuardianSep 11, 2026, 7:58 PM UTC
  • Arizona Takes on L'Oreal: Cancer Risk Allegations Spark Legal Battle - Devdiscourse

    DevdiscourseSep 11, 2026, 7:40 PM UTC
  • L’Oréal sued by Arizona over allegations it hid cancer risks of hair products - KTAR News 92.3 FM

    KTAR News 92.3 FMSep 11, 2026, 6:46 PM UTC
  • Arizona sues L’Oreal over alleged cancer risks in hair relaxers By Investing.com - Investing.com South Africa

    Investing.com South AfricaSep 11, 2026, 6:38 PM UTC
  • Arizona AG suing L'Oréal over hair product due to possible cancer risks - 12News

    12NewsSep 11, 2026, 6:22 PM UTC
  • Arizona Takes On L'Oreal Over Hair Relaxer Cancer Risks - Devdiscourse

    DevdiscourseSep 11, 2026, 6:05 PM UTC
  • Arizona sues L'Oréal for failing to disclose cancer risks associated with hair relaxers - courthousenews.com

    courthousenews.comSep 11, 2026, 5:59 PM UTC
  • ‘Unacceptable’: Arizona AG sues L’Oréal over alleged cancer-linked hair relaxers - AZ Family

    AZ FamilySep 11, 2026, 7:00 AM UTC
  • Claim That L’Oréal Faces ‘11,000 Cancer Lawsuits’ Lacks Important Context - english.factcrescendo.com

    english.factcrescendo.comJul 15, 2026, 4:53 AM UTC
  • Hair Straightener Use Linked to Higher Uterine Cancer Risk – What Frequent Users Should Know - inkl

    inklJul 5, 2026, 4:38 PM UTC
  • Sen. Hunter Bans Beauty Toxins, Strengthens Consumer Protections - The Chicago Crusader

    The Chicago CrusaderJul 4, 2026, 7:00 AM UTC

No recent PubMed signals. Monitoring is active — this section updates automatically.

No recent FDA signals. Monitoring is active — this section updates automatically.

PACERJPMLmdl-3060-stubDec 31, 2099, 12:00 AM UTC

Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation

PACER docket filed in JPML: The plaintiffs claim that multiple manufacturers produced and sold defective hair relaxer products, resulting in severe health issues such as uterine cancer, endometrial cancer, and ovarian cancer. The lawsuit targets a broad range of hair relaxer products from various companies. Legal claims includ

OTHERSep 30, 2026, 9:07 AM UTC

Authorization to Disclose Employment Information

This is a form authorizing the release of employment and medical records for litigation purposes, not a court order.

FILING_INSTRUCTIONSep 30, 2026, 9:07 AM UTC

Short-Form Complaint and Jury Demand

This is a short-form complaint form for plaintiffs in the Hair Relaxer MDL, incorporating the master long form complaint and designating venue pursuant to CMO No. 2.

PACERILND1:26-cv-11961Sep 29, 2026, 12:00 AM UTC

Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation

PACER docket entry from ILND: COMPLAINT filed by Carolyn Williams; Jury Demand. Filing fee $ 405, receipt number AILNDC-25732865.(Fantini, Joseph) (Entered: 09/29/2026)

PACERILND1:26-cv-11952Sep 29, 2026, 12:00 AM UTC

Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation

PACER docket entry from ILND: COMPLAINT filed by Pamela Ramsey; Jury Demand. Filing fee $ 405, receipt number AILNDC-25732083.(Glitz, Jessica) (Entered: 09/29/2026)

PACERILND1:26-cv-11949Sep 29, 2026, 12:00 AM UTC

Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation

PACER docket entry from ILND: COMPLAINT filed by Casondra Vanzandt; Jury Demand. Filing fee $ 405, receipt number AILNDC-25731882.(Glitz, Jessica) (Entered: 09/29/2026)

PACERILND1:26-cv-11946Sep 29, 2026, 12:00 AM UTC

Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation

PACER docket entry from ILND: COMPLAINT filed by Jada Banks; Jury Demand. Filing fee $ 405, receipt number AILNDC-25731382.(McCulley, Robert Bryant) (Entered: 09/29/2026)

PACERILND1:26-cv-11941Sep 29, 2026, 12:00 AM UTC

Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation

PACER docket entry from ILND: COMPLAINT filed by Charlie Minnifield; Jury Demand. Filing fee $ 405, receipt number AILNDC-25731218.(Wallace, Edward) (Entered: 09/29/2026)

PACERILND1:26-cv-11937Sep 29, 2026, 12:00 AM UTC

Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation

PACER docket entry from ILND: COMPLAINT filed by Shamaine Hinds; Jury Demand. Filing fee $ 405, receipt number AILNDC-25730740.(Shaw, Shakuwra) (Entered: 09/29/2026)

PACERILND1:26-cv-11933Sep 29, 2026, 12:00 AM UTC

Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation

PACER docket entry from ILND: COMPLAINT filed by Shirley Pruitt; Jury Demand. Filing fee $ 405, receipt number AILNDC-25730555.(Shaw, Shakuwra) (Entered: 09/29/2026)

Sign in to view all 201 filings

Workbench

Sign in to save litigations, capture notes, and monitor live signals. Sign in for unlimited.

LexGenius Ranking

79Score

Court, news, and regulatory activity are elevated

Evidence14 / 20
Momentum20 / 20
Exposure13 / 20
Regulatory13 / 20
Legal20 / 20

Monitoring

Live

monitoring

Last: Sep 30, 2026, 10:00 AM UTC

Next: —

Source Monitoring

PACER

39s

PACER

39s

Google News

39s

FAERS

39s

PubMed

15m 39s

Event feed

230

events detected

Google NewsPACER

AI Brief

Hair Relaxer remains mid-stage / daubert pending with 230 current signals in the accepted feed.

Overview

MDL 3060 is in final pretrial posture before bellwether trials. Judge Mary M. Rowland in the Northern District of Illinois assumed direct control of bellwether selection in April 2026, naming 10 cases from a 32-case discovery pool. Case-specific Daubert and summary judgment motions are due November 16, 2026, with initial trials anticipated in 2027. A Special Master continues facilitating settlement discussions.

Key developments

PACER court filing on Dec 31: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation. ‖ KOLD news on Sep 28: Arizona sues L’Oréal, claims hair relaxer chemicals raise women’s cancer risk - KOLD.

Generated Sep 30, 2026, 10:00 AM UTC

Tracked MDLs

MDL 3060

N.D. Ill.

Hair relaxer marketing, sales practices, and products liability

← Previous

EtO Sterilization

Follows ethylene oxide emissions litigation, sterilization-facility enforcement, and environmental-health reporting.

Next →

ParaGard

Monitors ParaGard IUD breakage litigation, device-safety developments, and clinical reporting.